"Hot and Spicy" Jia Ling drives the demand for weight loss? How big is the gap in the application of new drugs for the expansion of production by giants
六月清晨搅
发表于 2024-2-13 17:57:08
308
0
0
From public information, Jia Ling's weight loss mainly relies on controlling her diet and strengthening exercise, which is difficult for many people to persist in for a long time and ultimately leads to repeated failures. Is there a way to lose weight while lying down? Human glucagon like peptide-1 (GLP-1) receptor agonists seem to provide a possibility. GLP-1 drugs can help obese individuals who cannot achieve weight loss through lifestyle changes by inhibiting appetite and delaying gastric emptying through complex mechanisms. Since 2023, this type of drug has been on the rise globally, even experiencing supply shortages. Currently, the global competition for GLP-1 drugs not only revolves around product levels such as targets, dosage forms, and frequency of use, but has also expanded to the production capacity. In this regard, players in the GLP-1 weight loss track are each showing their abilities.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Can BeiGene PD-1, approved in the United States, grow into the next "blockbuster" level new drug?
- Renowned pharmaceutical giant announces that a heavyweight new drug has been approved! 1 bottle priced at 100000 yuan, how much impact will it have?
- Heavyweight new drug approved. Merck's stock price reaches a new historical high, from Wall Street to Lujiazui
- Urgent! The Japanese yen was suddenly hit by an air raid! How significant is the impact?
- How much room for imagination is there for the stock price to skyrocket for two consecutive days?
- Eli Lilly's new drug for Alzheimer's disease, Kisumla, has been approved by the US FDA
- Urgent response from JD after being liquidated by Wal Mart! How significant is the impact?
- Trump wins! These assets have skyrocketed! How significant is the impact? Latest interpretation
- Exhibits become commodities in seconds! Prostate cancer new drug approved in China, Pfizer Wang Yu: promoting China's new drug market to synchronize with the global market
- Eli Lilly's new Alzheimer's disease drug Donanemab has been approved for pricing in Japan